bet88 download

C-BATT Selected for $1 Million DOE Award to Aid the Commercialization of New Battery Anode Material

Transportation Secretary Pete Buttigieg snapped back Thursday at criticism from airline executives who say the Biden administration over-regulated them, pointing out that some of those airlines are making large profits despite new passenger-protection rules . Buttigieg said the rules his department has imposed, including automatic cash refunds after flights are canceled, enjoy broad public support and “will stand the test of time.” The comments came after the CEOs of Delta Air Lines and Southwest Airlines said they hoped the government will be more pro-business when President-elect Donald Trump returns to office. Delta CEO Ed Bastian said the Trump administration will be “a breath of fresh air” for his industry. “I know that some airline CEOs have expressed hopes that the next administration will be less passenger-friendly and more corporate-friendly than this administration,” Buttigieg responded during a news conference to discuss Thanksgiving travel. “The passenger protections that we have put in place deservedly enjoy broad public, bipartisan support. I just don't run into a lot of people who are against the idea that you ought to get an automatic refund without any hassle, for example.” Buttigieg argued that strong passenger protections are good for the airline business. “Some of these companies have been showing very healthy profits even at this new and higher level of consumer protection, demonstrating to me that these things can travel together,” he said. It appeared to be a reference to Delta, the most profitable U.S. airline in recent years. Delta earned $2.6 billion in the first nine months of this year and $4.6 billion last year. The airline industry has opposed many consumer-protections written by the Biden administration, even suing the Transportation Department to kill a rule requiring greater transparency over fees that airlines charge their passengers. Airlines also oppose a current department inquiry into their frequent-flyer programs . Bastian, the Delta CEO, said he expected the Transportation Department under Trump to “take a fresh look at the regulatory environment, the bureaucracy that exists in government, the level of overreach that we have seen over the last four years within our industry.” Southwest Airlines CEO Robert Jordan said last week, “We are hopeful for a DOT (Department of Transportation) that is maybe a little less aggressive in terms of regulating or rule-making.” Buttigieg noted that his department extracted a $140 million settlement from Southwest over widespread flight cancellations in December 2022 and is conducting a similar investigation into Delta, which canceled about 7,000 flights after a technology outage in July. He suggested airline CEOs should spend more time thinking about passengers and less about their regulator.

Enhancing payroll management with AILSU women control the glass, roll past NC State to pick up first ranked win of season

NEW YORK, Nov. 27, 2024 (GLOBE NEWSWIRE) -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) (“Titan”) today reported that it received a notice (the “5250 Notice”) on November 22, 2024 from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) advising the Company that it was not in compliance with Nasdaq’s continued listing requirements under the Nasdaq Listing Rule 5250(c)(1) (“Rule 5250”) as a result of its failure to file its Quarterly Report on Form 10-Q for the quarter ended September 30, 2024 (the “Q3 Form 10-Q”) in a timely manner. Under Nasdaq rules, the Company has 60 calendar days from receipt of the 5250 Notice or until January 21, 2025, to submit a plan to regain compliance with the Listing Rule. If Nasdaq accepts the Company’s plan, then Nasdaq may grant an exception of up to 180 calendar days from the due date of the Q3 Form 10-Q, or until May 19, 2025, to regain compliance. In response to the Notice, the Company is working to file the Q3 Form 10-Q as soon as possible in order to regain compliance with the Listing Rule. However, if the Company does not submit the Q3 Form 10-Q by January 21, 2025, the Company will submit a plan by such date to Nasdaq that outlines, as definitively as possible, the steps the Company will take to promptly file the Q3 Form 10-Q. Additionally, on November 25, 2024, the Company received a notice (the “5605 Notice”) from Nasdaq advising the Company that, following the appointment of Brynner Chiam as Acting Principal Executive Officer and Acting Principal Financial Officer of the Company on November 6, 2024, the Company no longer complies with Nasdaq’s audit committee requirements as set forth in Listing Rule 5605 (“Rule 5605”). Nasdaq advised that consistent with Listing Rule 5605(c)(4), Nasdaq will provide the Company with a cure period in order to regain compliance with Rule 5605: (i) until the earlier of the Company’s next annual shareholders’ meeting or November 6, 2025; or (ii) if the next annual shareholders’ meeting is held before May 5, 2025, then the Company must evidence compliance no later than May 5, 2025. The Company intends to appoint an additional independent director to the Board of Directors and the Audit Committee prior to the end of the cure periods. About Titan Pharmaceuticals Titan Pharmaceuticals, Inc. (NASDAQ: TTNP), formerly based in South San Francisco, CA, is a development stage company previously focused on developing proprietary therapeutics utilizing ProNeura® long-term, continuous drug delivery technology. In December 2021, Titan commenced a process to explore and evaluate strategic alternatives to enhance shareholder value. Forward-Looking Statements This press release may contain “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such statements include, but are not limited to, any statements relating to our product development programs and any other statements that are not historical facts. Such statements involve risks and uncertainties that could negatively affect our business, operating results, financial condition and stock price. Factors that could cause actual results to differ materially from management's current expectations include those risks and uncertainties relating to our ability to raise capital, the regulatory approval process, the development, testing, production and marketing of our drug candidates, patent and intellectual property matters and strategic agreements and relationships. We expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in our expectations or any changes in events, conditions or circumstances on which any such statement is based, except as required by law. A complete discussion of the risks and uncertainties that may affect Schmitt's business, including the business of its subsidiary, is included in “Risk Factors” in the Company's most recent Annual Report on Form 10-K as filed by the Company with the Securities and Exchange Commission. Media & Investor Contacts Brynner Chiam Acting Principal Executive Officer and Acting Principal Financial Officer (786) 769-7512

Lewandowski joins Ronaldo and Messi in Champions League 100-goal club. Haaland nets 2 but City draws

Losses for big technology stocks pulled major indexes lower on Wall Street. The S&P 500 fell 0.4% Wednesday. The Dow Jones Industrial Average slipped 0.3% from its record high a day earlier, and the Nasdaq composite lost 0.6%. Losses for Nvidia, Microsoft and Broadcom were the biggest weights on the market. Dell sank 12.2% after reporting revenue that fell shy of forecasts, and HP dropped 11.4% after giving a weaker-than-expected outlook. Treasury yields fell in the bond market. U.S. financial markets will be closed Thursday for Thanksgiving, and will reopen for a half day on Friday. THIS IS A BREAKING NEWS UPDATE. AP’s earlier story follows below. Stocks wavered in afternoon trading on Wednesday, as losses for several Big Tech companies offset gains elsewhere in the market. The S&P 500 fell 0.4% in afternoon trading, even though more stocks were rising than falling in the index. The Dow Jones Industrial Average fell 135 points, or 0.3%, as of 3:05 p.m. Eastern time. Both indexes set records on Tuesday. The Nasdaq composite fell 0.5%. Losses for tech heavyweights helped pull the broader market lower. Semiconductor giant Nvidia slipped 1.6%. Its huge value gives it outsized influence on market indexes. Microsoft fell 0.9% Several personal computer makers added to Big Tech's heavy weight on the market following their latest earnings reports. HP sank 11.8% after giving investors a weaker-than-expected earnings forecast for its current quarter. Dell slumped 11.9% after its latest quarterly revenue fell short of Wall Street forecasts. Gains for financial and health care companies helped counter Big Tech's downward pull. Visa rose 0.9% and Thermo Fisher Scientific added 2.3%. The U.S. economy expanded at a healthy 2.8% annual pace from July through September, according to the Commerce Department, leaving its original estimate of third-quarter growth unchanged. The growth was driven by strong consumer spending and a surge in exports. The update follows a report on Tuesday from the Conference Board that said confidence among U.S. consumers improved in November, but not by as much as economists expected. Consumers have been driving economic growth, but the latest round of earnings reports from retailers shows a mixed and more cautious picture. Department store operator Nordstrom fell 8.5% after warning investors about a trend toward weakening sales that started in late October. Clothing retailer Urban Outfitters jumped 19.1% after beating analysts’ third-quarter financial forecasts. Weeks earlier, retail giant Target gave investors a discouraging forecast for the holiday season, while Walmart provided a more encouraging forecast. Consumers, though resilient, are still facing pressure from inflation. The latest update from the U.S. government shows that inflation accelerated last month. The personal consumption expenditures index, or PCE, rose to 2.3% in October from 2.1% in September. Overall, the rate of inflation has been falling broadly since it peaked more than two years ago. The PCE, which is the Federal Reserve's preferred measure of inflation, was just below 7.3% in June of 2022. Another measure of inflation, the consumer price index, peaked at 9.1% at the same time. The latest inflation data, though, is a sign that the rate of inflation seems to be stalling as it falls to within range of the Fed's target of 2%. The central bank started raising its benchmark interest rate from near-zero in early 2022 to a two-decade high by the middle of 2023 and held it there in order to tame inflation. The Fed started cutting its benchmark interest rate in September, followed by a second cut in November. Wall Street expects a similar quarter-point cut at the central bank's upcoming meeting in December. “Today’s data shouldn’t change views of the likely path for disinflation, however bumpy," said David Alcaly, lead macroeconomic strategist at Lazard Asset Management. "But a lot of observers, probably including some at the Fed, are looking for reasons to get more hawkish on the outlook given the potential for inflationary policy change like new tariffs.” President-elect Donald Trump has said he plans to impose sweeping new tariffs on Mexico, Canada and China when he takes office in January. That could shock the economy by raising prices on a wide range of goods and accelerating the rate of inflation. Such a shift could prompt the Fed to rethink future cuts to interest rates. Treasury yields slipped in the bond market. The yield on the 10-year Treasury fell to 4.25% from 4.30% late Tuesday. The yield on the two-year Treasury, which more closely follows expected actions by the Fed, fell to 4.22% from 4.25% late Tuesday. U.S. markets will be closed Thursday for Thanksgiving, and will reopen for a half day on Friday. Damian J. Troise And Alex Veiga, The Associated PressChain Breaker Law Firm Expands Services to the UK Market with CBLFInMotion Ltd

RSA Conference 2025 Innovation Sandbox Contest Celebrates 20th Anniversary